People · Operator
Named in public records as an officer, director or promoter · active 2012–2023 · Computers, Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Technology Keiretsu, LLC | — | Computers | Series B | $24.8M | $66.4M | 2012 |
| Fuse Oncology, Inc. | — | Pharma | Series A | $11.8M | $79.4M | 2021 |
Jay Brennan at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jay Brennan on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Miller | 1 | 27 |
| Brian Kim | 1 | 8 |
| James Bauler | 1 | 2 |
| Steven Trenk | 1 | 2 |
| Steven L. Trenk | 1 | 1 |
| Michael G. Brennan | 1 | 1 |
| Gary E. Finkel | 1 | 1 |
| Michael W. Funk | 1 | 1 |
| Carl E. Ring, Jr. | 1 | 1 |
| M. Evan Moretzsky | 1 | 1 |
| Benjamin Sintay | 1 | 1 |
| John Strider | 1 | 1 |
| David Wiant | 1 | 1 |
| David Wiantt | 1 | 1 |
| MARK CANTALUPPI | 1 | 1 |
| MICHAEL E FUNK | 1 | 1 |
| Brian W. Kim | 1 | 1 |
| Ron W. Strauss | 1 | 1 |
| Bruce Flitcroft | 1 | 1 |
| Gary Finkel | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.